Motley Fool
Here Are My Top 2 No-Brainer Growth Stocks to Buy Now
📈
AI Sentiment
Highly Positive
10/10
- Home
- ISRG
as of 12-26-2025 3:43pm EST
$578.06
+$1.63
+0.28%
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | SUNNYVALE |
| Market Cap: | 202.9B | IPO Year: | 2000 |
| Target Price: | $593.23 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 7.56 | EPS Growth: | 21.56 |
| 52 Week Low/High: | $425.00 - $616.00 | Next Earning Date: | 01-22-2026 |
| Revenue: | $9,612,000,000 | Revenue Growth: | 22.18% |
| Revenue Growth (this year): | 21.13% | Revenue Growth (next year): | 14.95% |
AI-Powered ISRG Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 4 days ago
AI Recommendation
hold
Model Accuracy: 69.23%
69.23%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Intuitive Surgical Inc. (ISRG)
Brosius Mark
Sell
See Remarks
ISRG Dec 15, 2025
Avg Cost/Share
$548.49
Shares
464
Total Value
$254,499.36
Owned After
131
SEC Form 4
Brosius Mark
Sell
SVP & Chief Mfg and Supply Cha
ISRG Dec 15, 2025
Avg Cost/Share
$548.49
Shares
464
Total Value
$254,499.36
Owned After
131
SEC Form 4
Brosius Mark
Sell
SVP & Chief Mfg and Supply Cha
ISRG Dec 12, 2025
Avg Cost/Share
$547.36
Shares
4,500
Total Value
$2,463,120.00
Owned After
131
SEC Form 4
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Dec 10, 2025
Avg Cost/Share
$559.90
Shares
104
Total Value
$58,229.60
Owned After
0
SEC Form 4
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Dec 1, 2025
Avg Cost/Share
$568.99
Shares
125
Total Value
$71,123.75
Owned After
0
SEC Form 4
GUTHART GARY S
Sell
Executive Chair of the Board o
ISRG Dec 1, 2025
Avg Cost/Share
$570.89
Shares
22,806
Total Value
$13,019,721.90
Owned After
2,694
SEC Form 4
Charlton Henry L
Sell
EVP & Chief Commercial and Mkt
ISRG Nov 12, 2025
Avg Cost/Share
$580.00
Shares
13,731
Total Value
$7,963,980.00
Owned After
7,787
BARRATT CRAIG H
Sell
Director
ISRG Nov 12, 2025
Avg Cost/Share
$580.00
Shares
750
Total Value
$435,000.00
Owned After
0
SEC Form 4
Miller Brian Edward
Sell
EVP & Chief Digital Officer
ISRG Nov 10, 2025
Avg Cost/Share
$575.00
Shares
3,500
Total Value
$2,012,500.00
Owned After
5,758
Curet Myriam
Sell
EVP & Chief Medical Officer
ISRG Nov 10, 2025
Avg Cost/Share
$560.00
Shares
105
Total Value
$58,800.00
Owned After
0
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Brosius Mark | ISRG | See Remarks | Dec 15, 2025 | Sell | $548.49 | 464 | $254,499.36 | 131 | |
| Brosius Mark | ISRG | SVP & Chief Mfg and Supply Cha | Dec 15, 2025 | Sell | $548.49 | 464 | $254,499.36 | 131 | |
| Brosius Mark | ISRG | SVP & Chief Mfg and Supply Cha | Dec 12, 2025 | Sell | $547.36 | 4,500 | $2,463,120.00 | 131 | |
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Dec 10, 2025 | Sell | $559.90 | 104 | $58,229.60 | 0 | |
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Dec 1, 2025 | Sell | $568.99 | 125 | $71,123.75 | 0 | |
| GUTHART GARY S | ISRG | Executive Chair of the Board o | Dec 1, 2025 | Sell | $570.89 | 22,806 | $13,019,721.90 | 2,694 | |
| Charlton Henry L | ISRG | EVP & Chief Commercial and Mkt | Nov 12, 2025 | Sell | $580.00 | 13,731 | $7,963,980.00 | 7,787 | |
| BARRATT CRAIG H | ISRG | Director | Nov 12, 2025 | Sell | $580.00 | 750 | $435,000.00 | 0 | |
| Miller Brian Edward | ISRG | EVP & Chief Digital Officer | Nov 10, 2025 | Sell | $575.00 | 3,500 | $2,012,500.00 | 5,758 | |
| Curet Myriam | ISRG | EVP & Chief Medical Officer | Nov 10, 2025 | Sell | $560.00 | 105 | $58,800.00 | 0 |
Latest Intuitive Surgical Inc. News
ISRG Breaking Stock News: Dive into ISRG Ticker-Specific Updates for Smart Investing
Investor's Business Daily
Palantir, Nvidia Lead 5 Stocks Near Buy Points Heading Into Final Days Of 2025
➖
AI Sentiment
Neutral
5/10
Motley Fool
Have $2,000? 3 Top Robotics Stocks to Buy and Hold for at Least a Decade
📈
AI Sentiment
Highly Positive
8/10
Zacks
Here's Why Investors Should Hold Ensign Group Stock for Now
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
This Medical Robotics Name Wins FDA Greenlight; Its Stock Nears A Buy Point
📈
AI Sentiment
Highly Positive
8/10
Zacks
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Dow Jones Futures: S&P 500 Hits Record Close; Nvidia, Google Flash Buy Signals
📈
AI Sentiment
Highly Positive
8/10
Compare ISRG vs Leading Stocks
See how ISRG stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ISRG Intuitive Surgical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.